phone iconPhone: (401) 822-4673
phone iconFax: (401) 822-4676
Receive our Health e-Newsletter

News for Healthier Living

Metformin and ursodeoxycholic acid both fail to improve long COVID recovery in new clinical trial

A randomized clinical trial found that a two-week course of metformin or ursodeoxycholic acid (UDCA) did not meaningfully improve recovery from long COVID symptoms, despite earlier evidence suggesting metformin could lower long-term risk when taken during acute infection.

February 24, 2026


February 28 2026

February 27 2026

February 26 2026

February 25 2026

February 24 2026

February 23 2026

February 22 2026

February 21 2026

February 20 2026

February 19 2026

February 18 2026

February 17 2026

February 16 2026

February 15 2026

Angell Street Psychiatry
Copyright 2026 HealthBanks, Inc. All rights reserved.
Terms of Use | Privacy Policy